Cargando…

Management of mild hidradenitis suppurativa: our greatest challenge yet

Detalles Bibliográficos
Autores principales:	van der Zee, H.H., van de Bunte, M., van Straalen, K.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298862/ https://www.ncbi.nlm.nih.gov/pubmed/34608630 http://dx.doi.org/10.1111/bjd.20780

Ejemplares similares

High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa
por: van Straalen, K.R., et al.
Publicado: (2020)

Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches
por: Ardon, C.B., et al.
Publicado: (2020)

Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study
por: Vossen, Allard R. J. V., et al.
Publicado: (2017)

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2021)

Damage in hidradenitis suppurativa: receiving the deserved attention
por: Aarts, Pim, et al.
Publicado: (2022)

A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance
por: Vossen, A.R.J.V., et al.
Publicado: (2020)

Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?
por: van Straalen, K. R., et al.
Publicado: (2022)

New treatments and new assessment instruments for Hidradenitis suppurativa
por: van Straalen, Kelsey R., et al.
Publicado: (2022)

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers
por: Vossen, A.R.J.V., et al.
Publicado: (2018)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study
por: Bouwman, Klasiena, et al.
Publicado: (2022)

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study
por: Prens, L.M., et al.
Publicado: (2021)

Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis
por: Gudjonsson, Johann E., et al.
Publicado: (2020)

Atypical Hidradenitis Suppurativa on the Leg in a Psoriatic Patient
por: Yasuda, Masahito, et al.
Publicado: (2020)

Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy
por: Ring, Hans Christian, et al.
Publicado: (2022)

Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials
por: van der Zee, H.H., et al.
Publicado: (2019)

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group
por: Zouboulis, C.C., et al.
Publicado: (2018)

Cryosurgery-Induced Pneumomediastinum in a Young Woman with Hidradenitis Suppurativa
por: Gomes, Nuno Miguel Preto, et al.
Publicado: (2022)

Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Bertolotti, A., et al.
Publicado: (2021)

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
por: Crowley, JJ, et al.
Publicado: (2014)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

Surgical management of hidradenitis suppurativa
por: Gierek, Marcin, et al.
Publicado: (2022)

Compartmentalized Cytokine Responses in Hidradenitis Suppurativa
por: Kanni, Theodora, et al.
Publicado: (2015)

Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study
por: Willems, Damon, et al.
Publicado: (2021)

Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe
por: Willems, Damon, et al.
Publicado: (2023)

Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities
por: Lim, Ziying Vanessa, et al.
Publicado: (2016)

Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2023)

Systemic Immune-Inflammation Index (SII) Correlates with Disease Severity in Hidradenitis Suppurativa Patients
por: Hayran, Yıldız, et al.
Publicado: (2023)

Clinical Epidemiology and Management of Hidradenitis Suppurativa
por: Sayed, Christopher J., et al.
Publicado: (2021)

Novel cytokine and chemokine markers of hidradenitis suppurativa reflect chronic inflammation and itch
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease
por: Dufour, Deirdre Nathalie, et al.
Publicado: (2014)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Our Experience in Using Lateral Chest Flap to Treat Axillary Hidradenitis Suppurativa
por: Lahham, Salim Al, et al.
Publicado: (2022)

The most recent advances in understanding and managing hidradenitis suppurativa
por: Narla, Shanthi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ml8qppk3t10udhbcltnl3grdf8